Health Care & Life Sciences » Pharmaceuticals | Pharmesis International Ltd.

Pharmesis International Ltd.

Pharmesis International Ltd.
Stock Exchange Singapore Exchange
EPS
SGD0.01
Market Cap
SGD2.78 M
Shares Outstanding
23 M
Public Float
-

Profile

Address
No. 8 Yingbin Road
Chengdu Sichuan 611331
China
Employees -
Website http://www.pharmesis.com
Updated 07/08/2019
Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand.

Financials

View All

Xue Dan Wu
Chief Executive Officer & Executive Director
Jie Qi
Chief Operating Officer & Executive Director